News
Noticias
BIAL R&D Announces First Patient Dosed in its Phase 2 Clinical Trial of BIA 28-6156
BIAL R&D Announces First Patient Dosed in its Phase 2 Clinical Trial of BIA 28-6156 to Treat Parkinson’s Disease Patients With a Pathogenic Variant in the Glucocerebrosidase (GBA1) Gene.
BIAL Appoints Melanie Lee As Non-Executive Board Member
BIAL Appoints Melanie Lee As Non-Executive Board Member
BIAL appoints Max Bricchi as Chief Commercial Officer
BIAL has announced the appointment of Max Bricchi as Chief Commercial Officer (CCO) and Executive Board member.
Scientist.com Announces Launch of Research Marketplace for BIAL
PScientist.com Announces Launch of Research Marketplace for BIAL BIAL partners with Scientist.com to improve and digitize internal R&D
BIAL inaugurates a new antibiotics production plant and expands its industrial area
Prime Minister António Costa unveiled a new antibiotics production unit and the expansion of the industrial building of the BIAL group this morning. These two new facilities are part of the expansion project of the BIAL Campus, installed in an area of over 24 hectares and involving an investment of 30 million euros
BIAL unveils its new Lake House
This Thursday, BIAL unveils its new company headquarters building: "Lake House". Designed from scratch by architect Carlos Prata, this space is specially designed to encourage open communication and interaction between all employees, regardless of their department or specialisation.
Keep it ON – Have you visited the Training Area?
There are new ways to keep healthy, active and positive while living with Parkinson’s. Launched for the first time in April, the Training Area is a feature on the Keep It ON website, that features a specialised compilation of resources that is a step forward towards the empowerment of patients. The content for this Training Area is related to “exercise”, “nutrition”, “voice” and “cognition” and has been developed in partnership with European Parkinson's Disease Association (EPDA), as well as experts in these areas. The resources produced have been published the last months on the Keep It ON website, where they can be viewed, free of charge, in your preferred language (Portuguese, Spanish, German or English). Visit now the new contents here: https://www.bial-keepiton.com/training-area/ #KeepItOn #BialParkinson
Epilepsy: Tonic App has updated digital contents
In May, following our long-lasting commitment to epilepsy in Portugal, we’ve started a partnership with Tonic App, an app designed by physicians and for physicians to provide new digital resources focused on this and other pathologies for all Portuguese medical doctors. Now, three new medical algorithms were made available in the app - Classification & diagnosis, Treatment and Referral – that will provide physicians with new tools for clinical practice in epilepsy. These resources were developed by Dr. Cláudia Lima, Neurology resident at Centro Hospitalar e Universitário de Coimbra. If you are a medical doctor, download the app on your phone by searching “Tonic App” in the App Store or Google Play, or download it directly through this link.
BIAL appoints Joerg Holenz as R&D General Manager
BIAL today announced the appointment of Joerg Holenz as R&D General Manager, a role that he will assume alongside that of member of the Board of Directors.